Use Of Pcsk9 Inhibitors In Patients At Prohibitive Cardiovascular Risk: The Interventional Cardiologist'S Point Of View On Rapidity Of Action, Efficacy, Prescriptive Appropriateness And Pharmacological Reimbursement
GIORNALE ITALIANO DI CARDIOLOGIA(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要